| 4.40 Data as of May 17 |  +0.1199 / +2.80%Today’s Change | 3.60 Today|||52-Week Range 45.00 | -65.85% Year-to-Date |
| Previous close | 4.28 |
| Today’s open | 4.20 |
| Day’s range | 4.00 - 4.40 |
| Volume | 6,177 |
| Average volume (3 months) | 14,917 |
| Market cap | $11.4M |
| Dividend yield | -- |
| Earnings growth (last year) | -55.56% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -68.82% |
| P/E ratio | NM |
| Price/Sales | 459.14 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| CXMCardium Therapeutics... | -0.00 | -3.73% |
| ICCCImmuCell Corp | -0.19 | -5.22% |
| CBMXCombiMatrix Corp | +0.01 | +0.30% |
| --Alternative Energy A... | -0.30 | -50.00% |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $100.5K |
| Annual profit (last year) | -$15.7M |
| Net profit margin | -15,631.28% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive & Financial Officer Michael B. Jebsen, CPA |
Executive Vice President- Clinical Development Timothy Bradshaw, PhD |
Corporate headquarters Morrisville, North Carolina |
.
